PET-CT after radiofrequency ablation of colorectal liver metastases:Suggestions for timing and image interpretation

European Journal of Radiology

Volumn 82, Issue 12, 2013, Pages 2169-2175

  Nielsen, Karin ^a   Van Tilborg, Aukje A J M ^a   Scheffer, Hester J ^a   Meijerink, Martijn R ^a   De Lange De Klerk, Elly S M ^a   Meijer, Sybren ^a   Comans, Emile F I ^a   Van Den Tol, M Petrousjka ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

FDG PET; Liver; Liver neoplasms secondary; Local; Neoplasm recurrence; Neoplasms surgery; Radiofrequency ablation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE CLEARANCE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LAPAROTOMY; LOCAL SITE RECURRENCE; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECEIVER OPERATING CHARACTERISTIC; TIME LAPSE IMAGING;

FDG-PET; LIVER NEOPLASMS/SECONDARY; LIVER NEOPLASMS/SURGERY; LOCAL; NEOPLASM RECURRENCE; RADIOFREQUENCY ABLATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84890797869     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2013.08.024     Document Type: Article

References (30)

1. Cook AD, Single R, McCahill LE. Surgical resection of primary tumors inpatients who present with stage IV colorectal cancer: an analysis of surveil-lance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005;12(8):637-45.
2. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes followinghepatic resection, radiofrequency ablation, and combined resection/ablationfor colorectal liver metastases. Ann Surg 2004;239(6):818-25.
3. Smith MD, McCall JL. Systematic review of tumour number and outcome afterradical treatment of colorectal liver metastases. Br J Surg 2009;96(10):1101-13.
4. Siperstein AE, Berber E, Ballem N, Parikh RT. Survival after radiofre-quency ablation of colorectal liver metastases: 10-year experience. Ann Surg 2007;246(4):559-65.
5. Van Tilborg AAJM, Meijerink MR, Sietses C, et al. Long-term results of radiofre-quency ablation for unresectable colorectal liver metastases: a potentiallycurative intervention. Br J Radiol 2011;84(1002):556-65.
6. Lee WS, Yun SH, Chun HK, et al. Clinical outcomes of hepatic resection andradiofrequency ablation in patients with solitary colorectal liver metastasis. JClin Gastroenterol 2008;42(8):945-9.
7. Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009clinical evidence review on radiofrequency ablation of hepatic metastases fromcolorectal cancer. J Clin Oncol 2010;28(3):493-508.
8. Nielsen K, van Tilborg AAJM, Meijerink MR, et al. Incidence and treatment oflocal site recurrences following RFA of colorectal liver metastases. World J Surg 2013;37(6):1340-7.
9. Kuehl H, Antoch G, Stergar H, et al. Comparison of FDG-PET, PET/CT and MRI forfollow-up of colorectal liver metastases treated with radiofrequency ablation:initial results. Eur J Radiol 2008;67(2):362-71.
10. Blokhuis TJ, van der Schaaf MC, van den Tol MP, Comans EFI, Manoliu RA,van der Sijp JR. Results of radio frequency ablation of primary and secondaryliver tumors: long-term follow-up with computed tomography and positronemission tomography-18F-deoxyfluoroglucose scanning. Scand J Gastroen-terol Suppl 2004;(241):93-7.
11. Sahin DA, Agcaoglu O, Chretien C, Siperstein A, Berber E. The utility ofPET/CT in the management of patients with colorectal liver metastasesundergoing laparascopic radiofrequency thermal ablation. Ann Surg Oncol 2012;19(3):850-5.
12. Langenhoff BS, Oyen WJG, Jager GJ, et al. Efficacy of fluorine-18-deoxyglucosepositron emission tomography in detecting tumor recurrence after localablative therapy for liver metastases: a prospective study. J Clin Oncol 2002;20(22):4453-8.
13. Chen W, Zhuang H, Cheng G, Torigian DA, Alavi A. Comparison of FDG-PET, MRIand CT for post radiofrequency ablation evaluation of hepatic tumors. Ann NuclMed 2012.
14. Sahin D, Agcaoglu O, Chretien C, Siperstein A, Berber E. The utility ofPET/CT in the management of patients with colorectal liver metastasesundergoing laparascopic radiofrequency thermal ablation. Ann Surg Oncol 2012;19(3):850-5.
15. Wiering B, Krabbe PFM, Jager GJ, Oyen WJ, Ruers TJ. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectalliver metastases. Cancer 2005;104(12):658-2670.
16. Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modalityPET/CT in preoperative staging. Radiology 2003;229(2):26-533.
17. Donckier V, Van Laethem JL, Goldman S, et al. fluorodeoxyglucosepositron emission tomography as a tool for early recognition of incompletetumor destruction after radiofrequency ablation for liver metastases. J SurgOncol 2003;84(4):215-23.
18. Khandani AH, Calvo BF, ONeil BH, Jorgenson J, Mauro MA. A pilot study of early18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of livermetastases. AJR Am J Roentgenol 2007;189(5):1199-202.
19. Ruers TJM, Langenhoff BS, Neeleman N, et al. Value of positron emissiontomography with fluorodeoxyglucose in patients with colorectal livermetastases: A prospective study J Clin Oncol 2002, 20, 2, 388-95
20. Giordano P, Efron J, Vernava AM, Weiss EG, Nogueras JJ, Wexner SD. Strategiesof follow-up for colorectal cancer: a survey of the American Society of Colonand Rectal Surgeons. Tech Coloproctol 2006;10(3):199-207.
21. Bhattacharjya S, Aggarwal R, Davidson BR. Intensive follow-up after liverresection for colorectal liver metastases: results of combined serial tumourmarker estimations and computed tomography of the chest and abdomen - aprospective study. Br J Cancer 2006;95(1):21-6.
22. Gomez D, Sangha VK, Morris-Stiff G, et al. Outcomes of intensive surveillanceafter resection of hepatic colorectal metastases. Br J Surg 2010;97(10):1552-60.
23. Jones RP, Jackson R, Dunne DFJ, et al. Systematic review and meta-analysisof follow-up after hepatectomy for colorectal liver metastases. Br J Surg2012;99(4):477-86.
24. Desch CE, Benson AB, Somerfield MR, et al. Colorectal cancer surveillance: 2005update of an American Society of Clinical Oncology practice guideline. J ClinOncol 2005;23(33):8512-9.
25. Poulou LS, Ziakas PD, Ziogas DC, et al. FDG-PET for detecting local tumorrecurrence of ablated liver metastases: a diagnostic meta-analysis. Biomarkers 2012;17(6):32-538.
26. Liu ZY, Chang ZH, Lu ZM, Guo QY. Early PET/CT after radiofrequency abla-tion in colorectal cancer liver metastases: is it useful? Chin Med J (Engl)2010;123(13):1690-4.
27. Lubezky N, Metser U, Geva R, et al. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scanand computerized tomography (CT) in restaging patients with hepaticcolorectal metastases following neoadjuvant chemotherapy: comparisonwith operative and pathological findings. J Gastrointest Surg 2007;11(4):472-8.
28. Bipat S, van Leeuwen MS, Comans EFI, et al. Colorectal liver metas-tases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology2005;237(1):23- 131.
29. Boellaard R, ODoherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM pro-cedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med MolImaging 2010;37(1):181-200.
30. Wiering B, Adang EMM, van der Sijp JRM, et al. Added value of positron emissiontomography imaging in the surgical treatment of colorectal liver metastases.Nucl Med Commun 2010;31(11):938-44.